Welcome to

Our Event

Following the success of our inaugural event, MarketsandMarkets is proud to announce the 2nd Annual Next Gen Immuno-Oncology Congress to be held on 13th and 14th March 2018  at the Thistle  London Heathrow Terminal 5 inLondon, UK. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADC’s, Bispecific Antibodies and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and pe?rsonalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

Awesome Image




0 Hours of Networking


Full Name *
Email Id *

Company *
Job Title *

Country Code *
Phone Number *

Country *


Our Speakers

 Randolf	Kerschbaumer
Randolf Kerschbaumer

Founder and Managing Director, OncoOne, Austria

Anat	Globerson
Anat Globerson

Laboratory Manager and Senior Scientist, Tel Aviv Sourasky Medical Center, Israel

Ann White
Ann White

Senior Principal Scientist, UCB Celltech

Anneli Anderson
Anneli Anderson

Scientific Project Manager, Nebion, Switzerland

Annelise 	Vuidepot
Annelise Vuidepot

VP, Head of Oncology Pipeline and Research, Immunocore

Brian Champion
Brian Champion

CSO, PsiOxus Therapeutics

Carlo Boutton
Carlo Boutton

Director Technology & Information Management, Ablynx, Belgium

Cesar Evaristo
Cesar Evaristo

Miltenyi Biotec,Team Coordinator, Germany

Know All Speakers

Event Sponsors





Sponsors & Exhibitors

Official Logistics Partner

Become Sponsor Know All Sponsors

Media Partners

Supporting Association

Submit your Poster Presentation


Bath Road, Longford London UB7 0EQ Hotel: +44 (0) 800 330 8086 / +44 (0) 20 8624 4010

Lonza provides the pharma market with the tools that life-science researchers use to develop and test therapeutics, beginning with basic research stages on to the final product release. Lonza’s bioscience products and services range from cell culture and discovery technologies for research to quality control tests and software that ensures product quality. Lonza Bioscience Solutions serves research customers worldwide in pharmaceutical, biopharmaceutical, biotechnology and personal care companies. The company delivers physiologically relevant cell biology solutions and complete solutions for rapid microbiology.

View on Map
Image Gallery